Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Medical notes 
Background Briefings 
Education 
Sport 
Entertainment 
Talking Point 
In Depth 
AudioVideo 
Friday, 10 December, 1999, 02:45 GMT
Skin test discovered for hereditary cancers

DNA DNA flaw in cells can cause tumours


Scientists believe they have developed a screening technique for members of families suffering from types of hereditary cancers.

The Imperial Cancer Research Fund says investigations of skin lesions may allow doctors to identify people likely to suffer from a group of cancers, particularly those of the colon.

By looking at skin warts, benign growths and malignant skin tumours in members of families with a history of HNPCC - hereditary non-polyposis colorectal cancer syndrome - it may be possible to identify people at high risk.

HNPCC has been linked to a defect in the repair mechanism for cells. Cells should replicate their DNA when they divide but if they do not they can cause alterations to microsatellites - the short repetitive sequences of genetic code contained in DNA.

This phenomenon, known as microsatellite instability (MSI), can cause tumours to develop.

Skin lesions

"We wanted to see if MSI is also present in skin lesions in patients belonging to HNPCC families," said Dr Veronique Bataille, of the Imperial Cancer Research Fund's Skin Tumour Laboratory.

"We discovered the presence of MSI in different types of benign skin lesions in these families, so the skin appears to be a marker of the genetic faults that may increase the risk of developing internal tumours."



The skin appears to be a marker of the genetic faults that may increase the risk of developing internal tumours
Dr Veronique Bataille
Dr Bataille and her team inspected skin lesions of families with and without a history of hereditary colon cancer. In those with no family history, MSI was not found to be present.

"Detecting MSI in the skin could potentially be used in clinical practice to screen individuals in families at risk," said Dr Bataille.

There are about 3,000 HNPCC sufferers in the UK and of those, about 30% are also susceptible to other types of tumours, particularly those of the womb and the ovary.

Professor Soren Bentzen of the Gray Laboratory Cancer Research Trust at Mount Vernon Hospital, Middlesex, who has carried out studies of HNPCC in Denmark, said the screening proposal was "intriguing".

Discovering patterns for the colorectal cancer has proved difficult because of its sporadic occurrence, he said.

"You still need to base a screening strategy on some kind of family history because HNPCC is such a rare condition," he said. "But I can see why members of families where there is a high risk might want to have the test done."

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE

See also:
19 Nov 99 |  Medical notes
Bowel cancer
17 Feb 99 |  Health
First cancer screening programme for men
15 Feb 99 |  Health
Huge variation in cancer survival rates

Internet links:

The BBC is not responsible for the content of external internet sites
Links to other Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories